However, L can act on FGR1–FGR4, PDGFR-b, RET, and c-kit, although its main effect is considered to be on VEGFR-1, VEGFR-2, and VEGFR-3 and, hence, on tumor vascularization. Here, FLT1 is linked to neoplasm.